NM_030928.4:c.*6G>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_030928.4(CDT1):c.*6G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00354 in 1,579,418 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 59 hom., cov: 35)
Exomes 𝑓: 0.0022 ( 60 hom. )
Consequence
CDT1
NM_030928.4 3_prime_UTR
NM_030928.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.423
Publications
3 publications found
Genes affected
CDT1 (HGNC:24576): (chromatin licensing and DNA replication factor 1) The protein encoded by this gene is involved in the formation of the pre-replication complex that is necessary for DNA replication. The encoded protein can bind geminin, which prevents replication and may function to prevent this protein from initiating replication at inappropriate origins. Phosphorylation of this protein by cyclin A-dependent kinases results in degradation of the protein. [provided by RefSeq, Mar 2011]
CDT1 Gene-Disease associations (from GenCC):
- Meier-Gorlin syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- Meier-Gorlin syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 16-88808284-G-C is Benign according to our data. Variant chr16-88808284-G-C is described in ClinVar as Benign. ClinVar VariationId is 128663.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0518 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0158 AC: 2403AN: 152240Hom.: 57 Cov.: 35 show subpopulations
GnomAD3 genomes
AF:
AC:
2403
AN:
152240
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00535 AC: 1018AN: 190250 AF XY: 0.00498 show subpopulations
GnomAD2 exomes
AF:
AC:
1018
AN:
190250
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00222 AC: 3165AN: 1427060Hom.: 60 Cov.: 34 AF XY: 0.00223 AC XY: 1577AN XY: 706868 show subpopulations
GnomAD4 exome
AF:
AC:
3165
AN:
1427060
Hom.:
Cov.:
34
AF XY:
AC XY:
1577
AN XY:
706868
show subpopulations
African (AFR)
AF:
AC:
1790
AN:
32802
American (AMR)
AF:
AC:
140
AN:
39312
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25414
East Asian (EAS)
AF:
AC:
1
AN:
38108
South Asian (SAS)
AF:
AC:
828
AN:
82382
European-Finnish (FIN)
AF:
AC:
0
AN:
49228
Middle Eastern (MID)
AF:
AC:
23
AN:
5744
European-Non Finnish (NFE)
AF:
AC:
73
AN:
1094950
Other (OTH)
AF:
AC:
310
AN:
59120
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
152
304
456
608
760
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0159 AC: 2420AN: 152358Hom.: 59 Cov.: 35 AF XY: 0.0159 AC XY: 1184AN XY: 74516 show subpopulations
GnomAD4 genome
AF:
AC:
2420
AN:
152358
Hom.:
Cov.:
35
AF XY:
AC XY:
1184
AN XY:
74516
show subpopulations
African (AFR)
AF:
AC:
2232
AN:
41584
American (AMR)
AF:
AC:
110
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5180
South Asian (SAS)
AF:
AC:
41
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11
AN:
68034
Other (OTH)
AF:
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
117
234
352
469
586
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
29
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Apr 02, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Feb 04, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.